2017 Partners

The Medicine Maker focuses on the development and manufacture of drugs and biological medicines. Our pragmatic, engaging articles tell the stories behind the field’s biggest concepts and innovations.

SCIAD Newswire is a news distribution business for the life science, biotech and healthcare sectors. We distribute our customers’ news to editors, reporters and social media influencers worldwide who write about healthcare, biotech and life science.

We founded Sciad Newswire after recognising that companies wanting to make media announcements required an alternative to full service PR agencies. We communicate closely with journalists and PR professionals to gain feedback and maintain high quality standards.

With more than 20 years’ experience working in healthcare and science communications we have unique and unrivalled databases of contacts who want to read and publish new developments for their readers.

The REMEDIES (RE-configuring MEDIcines End-to-end Supply Project is headed up by GlaxoSmithKline with research led by the University of Cambridge’s Institute for Manufacturing.

Launched in 2014, REMEDIES is a broad-based collaboration examining how the multi-billion pound global medicines manufacture and supply sector can be reshaped to meet the needs, expectations and budgets of the 21st Century.

REMEDIES brings together academics, regulators and healthcare professionals alongside teams from global pharmaceutical companies, major contract manufacturing organisations, equipment manufacturers and international logistics specialists, to scrutinise the many different elements of the medicines end-to-end supply chain – from patent to patient.

The project, has been funded by its industry partners and the UK Government’s Advanced Manufacturing Supply Chain Initiative.

For more information on the REMEDIES project and partner organisations, please visit the following website, www.remediesproject.com

Innovation DB has the world’s largest database of its kind, promoting novel technologies to corporate R&D teams that may be interested in them. This is currently being significantly expanded, to cover universities and companies across 70 countries, with improved search functionality.

It operates also a Forum, which exists to bring together those with novel technologies and those who wish to commercialise them. This includes universities, research institutions, research councils and government-funded science and technology laboratories and businesses – from global corporations to start-ups working with emerging technologies and business people who want to be part of an emerging tech company.

We also run events, usually focussed on a specific technological theme, so that our customers and partners and others can actually meet to discuss their innovations.

Manufacturing Chemist is established and respected in the global pharmaceutical industry.
Published by HPCi Media, daily, weekly and monthly through its web and print options, all products work together to give you the insight and foresight to aid planning and decision making.

Stevenage Bioscience Catalyst (SBC) opened as the UK’s first open innovation biomedical campus in 2012, and combines a unique blend of infrastructure and virtual networks to drive collaboration. Backed by a unique partnership between Government, GlaxoSmithKline and the Wellcome Trust, the remit was, and remains, to catalyse innovation for patient benefit in a phased development. SBC has a strong commitment to companies that focus on high quality science and share its vision, and its development of activity clusters and direct access to the expertise of a major pharmaceutical company are among its unique characteristics.

There is start-up and grow-on space for companies, plus a commercially focused management team viewed as a leader in UK incubation. With Phase 1 at capacity, Phase 2 is in development for the continuation of the collaborative vision, with a focus on convergent medical technologies. Co-located with GlaxoSmithKline in Stevenage, Stevenage Bioscience Catalyst is located close to both London and Cambridge.

For more information, please go to www.stevenagecatalyst.com.

The Patient Information Forum (PIF) is the UK membership organisation and network for people working in, and involved with, healthcare information and support.

The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.

We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.

Bionow supports business growth, competitiveness and innovation within the biomedical and life science sectors across Northern England. Our membership services add value and cost-efficiency to scientific, clinical and business operations within early stage and growth-oriented firms.

Our membership base includes startups and early stage firms as well as established growth-oriented companies. Bionow’s membership offering focuses upon the specific needs of firms at their different stages of development, including dedicated business support programmes, shared procurement schemes with significant cost savings, exclusive insurance benefits, recruitment and training services, local and national events and access to a vibrant network of businesses.